Implementation Guide CH VACD
4.0.1 - trial-use
This page is part of the CH VACD (R4) (v4.0.1: STU 4) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Generated Narrative: Immunization
Resource Immunization "TCF01-IMMUN3"
Profile: CH VACD Immunization
Author of the content: Patient/TC-patient " WEGMUELLER"
CH VACD Extension Immunization Medication Reference: Medication/TC-IMMUN-MEDIC-HAVRIX1440
identifier: id: 94bdf3b1-0c04-42d3-9901-7e68f124f5ff
status: completed
vaccineCode: Havrix 1440 (Swiss Medic Authorized Vaccines Codesystem#558)
patient: Patient/TC-patient " WEGMUELLER"
occurrence: 2021-05-27
recorded: 2021-05-27 00:00:00+0200
lotNumber: AHAVB946A
route: Intramuscular use (standardterms.edqm.eu#20035000)
Actor |
PractitionerRole/TC-HCP1-ORG1-ROLE-performer |
note: Der Patient hat diese Impfung ohne jegliche Nebenwirkungen gut vertragen. (By Practitioner/TC-HCP1-C1 @2021-06-02)
TargetDisease | DoseNumber[x] |
Viral hepatitis, type A (disorder) (SNOMED CT#40468003) | 1 |